arrow
J

Josef S Smolen

Medical University of Vienna
H指数:87
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis

CT-P47生物类似药与参比托珠单抗的疗效和安全性比较:一项在类风湿关节炎患者中进行的随机、活性对照、双盲、III期研究的1年结果

2025-07-120
OA
DO HIGH RHEUMATOID FACTOR LEVELS IMPACT RESPONSE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH INADEQUATELY CONTROLLED RHEUMATOID ARTHRITIS? A POST HOC ANALYSIS OF THE PHASE 3B REALISTIC TRIAL

高类风湿因子水平是否影响certolizumab pegol在控制不佳的类风湿关节炎患者中的应答?——REALISTIC三期B阶段试验的事后分析

2024-06-010
PRE
Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries

来自14个国家的222名银屑病关节炎患者的患者定义的耀斑和疾病活动恶化

2023-05-012
OAAI
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

在非血清转化的免疫抑制患者中,异源载体与同源mRNA新型冠状病毒肺炎加强疫苗接种: 一项随机对照试验

2022-09-1224
OAAI
Presence of anti-acetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis

炎性关节炎和其他风湿性疾病中抗乙酰化肽抗体 (AAPA) 的存在表明对早期类风湿性关节炎的鉴别诊断能力

2021-07-2313
OAAI
microRNA-146a controls age-related bone loss
2020-10-2131
OAAI